INiBICA

PROYECTOS INTERNACIONALES

GALATEA - diGitAL twin frAmework for TailorEd infAnt nutrition (GALATEA)

Investigador principal: Simón Lubián (CO20)

Más información

Fechas: 01 de septiembre de 2024 – 31 de agosto de 2028

Socios: SCUOLA UNIVERSITARIA PROFESSIONALE DELLA SVIZZERA ITALIANA (Switzerland) | TOELT GMBH (Switzerland)

Presupuesto: 77.400,00 €

The European Youth Cancer Network (YARN)

Investigador principal: David Jiménez Pavon (CO8)

Más información

Fechas: 01 de julio de 2025 – 30 de junio de 2028

Presupuesto: 285.621,52 €

Persistent Atrial fibrillation: SUbstrate tArgeteD stratEgy (PERSUADE)

Investigador principal: Etelvino Silva (CO31)

Más información

Fechas: 01 de enero de 2024 – 31 de diciembre de 2026

Socios: (AT) BUNDESMINISTERIUM FUR BILDUNG, WISSENSCHAFT UND FORSCHUNG – (BMBWF) | (AT) ÖSTERREICHISCHER WISSENSCHAFTSFONDS – (FWF) | (BE) EIGEN VERMOGEN VAN HET INSTITUUT VOOR LANDBOUW- EN VISSERIJONDERZOEK – (EV ILVO) | (BE) FONDS DE LA RECHERCHE SCIENTIFIQUE-FNRS – (FRS- FNRS) | (BE) FONDS VOOR WETENSCHAPPELIJK ONDERZOEK-VLAANDEREN – (FWO) | (CZ) MINISTRY OF HEALTH – (MZCR) | (DE) DEUTSCHES ZENTRUM FUR LUFT – UND RAUMFAHRT EV – (DLR) | (DE) BUNDESMINISTERIUM FÜR BILDUNG UND FORSCHUNG – (BMBF) | (DK) INNOVATIONSFONDEN – (IFD) | (EE) THE ESTONIAN RESEARCH COUNCIL – (ETAG) | (EG) ACADEMY OF SCIENTIFIC RESEARCH AND TECHNOLOGY – (ASRT) | (EL) GENIKI GRAMMATIA EREVNAS KAI KAINOTOMIAS – (GSRI) | (ES) INSTITUTO DE SALUD CARLOS III – (ISCIII) | (ES) AGENCIA ESTATAL DE INVESTIGACIÓN – (AEI) | (ES) FUNDACIÓN PARA EL FOMENTO EN ASTURIAS DE LA INVESTIGACIÓN CIENTÍFICA Y TECNOLOGÍA – (FICYT) | (ES) CONSEJERÍA DE SALUD Y CONSUMO DE LA JUNTA DE ANDALUCÍA – (CSCJA) | (ES) AGENCIA DE CIENCIA COMPETITIVIDAD EMPRESARIAL E INNOVACION ASTURIANA – (SEKUENS) | (FR) AGENCE NATIONALE DE LA RECHERCHE – (ANR) | (FR) EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK – (ECRIN) | (FR) MINISTÈRE DE LA SANTÉ ET DE L’ACCÈS AUX SOINS – (Fr-MoH) | (HU) NEMZETI KUTATASI FEJLESZTESI ES INNOVACIOS HIVATAL – (NKFIH) | (IE) THE HEALTH RESEARCH BOARD – (HRB) | (IL) MINISTRY OF HEALTH – (CSO-MOH) | (IT) MINISTERO DELLA SALUTE – (IT-MOH) | (IT) MINISTERO DELL’UNIVERSITÀ E DELLA RICERCA – (MUR) | (LT) LIETUVOS MOKSLO TARYBA – (LMT) | (LV) LATVIJAS ZINATNES PADOME – (LCS) | (NL) NEDERLANDSE ORGANISATIE VOOR WETENSCHAPPELIJK ONDERZOEK – (NWO) | (NL) ZORGONDERZOEK NEDERLAND ZON – (ZonMw) | (NO) NORGES FORSKNINGSRAD – (RCN) | (PL) NARODOWE CENTRUM BADAN I ROZWOJU – (NCBR) | (PT) AGÊNCIA DE INVESTIGAÇÃO CLÍNICA E INOVAÇÃO BIOMÉDICA – (AICIB) | (PT) FUNDAÇÃO PARA A CIENCIA E A TECNOLOGIA – (FCT) | (RO) UNITATEA EXECUTIVA PENTRU FINANTAREA INVATAMANTULUI SUPERIOR A CERCETARII DEZVOLTARII SI INOVARII – (UEFISCDI) | (SK) SLOVENSKÁ AKADÉMIA VIED – (SAS) | (SK) BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIED, VEREJNA VYSKUMNA INSTITUCIA – (BMC-SAS) | (TR) TÜRKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU – (TUBITAK)

Presupuesto: 249.623,00 €

CHILD MENTAL HEALTH LITERACY: CO-CREATING AND EVALUATING A WHOLE-SCHOOL INTERVENTION AND DEVELOPING AND VALIDATING AN AD HOC SCALE (CHILD MENTAL HEALTH)

Investigador principal: Juan Luis González Caballero (CO15)

Más información

Fechas: 01 de enero de 2024 – 31 de diciembre de 2026

Luminescent Implants as ports for light-based therapies (PHOtoTHERAPORT)

Investigador principal: Esther Berrocoso (CO9)

Más información

Fechas: 01 de enero de 2024 – 31 de diciembre de 2026

Presupuesto: 405.500,00 €

A Randomised, Embedded, Multi-factorial, Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP)

Investigador principal: Ángel Estella (EM11)

Más información

Fechas: 02 de febrero de 2023 – 28 de marzo de 2026

Presupuesto: 3.750,00 €

pREVention and management tools for rEducing antibiotic Resistance in high prevalence Settings (REVERSE)

Investigador principal: Salvador López Cárdenas (EM11)

Más información

Fechas: 01 de julio de 2021 – 30 de septiembre de 2025

Socios: University of Zurich, Partner Lead (Project Coordinator): Walter Zingg, Partner Lead (WP5): Lauren Clack | Andalusian Health Service, Partner Lead: Jesús Rodríguez Baño | Barcelona Institute for Global Health, Partner Lead: Elisa Sicuri | National and Kapodistrian University of Athens, Partner Lead: George Daikos | Tel Aviv Sourasky Medical Center, Partner Lead: Yehuda Carmeli | UK Health Security Agency, Partner Lead: Julie Robotham | University Medical Centre Utrecht, Partner Lead: Jan Kluytmans | University of Florence, Partner Lead: Gian Maria Rossolini | University of Geneva, Partner Lead: Stephan Harbarth | University of Medicine and Pharmacy Carol Davila, Partner Lead: Adriana Hristea | University of Oxford, Partner Lead: Koen Pouwels | University of Verona, Partner Lead: Evelina Tacconelli

Presupuesto: 300.000,00 €

Pathophysiology of neural circuits underlying pain in prodromal to advanced Parkinson's Disease

Investigador principal: Esther Berrocoso (CO9)

Más información

Fechas: 01 de octubre de 2023 – 30 de septiembre de 2025

Socios: The Michael J. Fox Foundation (MJFF) engages companies to enhance our programs through funding, in-kind contributions, strategic input and more. Partners make these key MJFF initiatives posible | Parkinson’s Progression Markers Initiative, A landmark longitudinal study to identify objective measures of Parkinson’s disease, PPMI is an MJFF-sponsored study, funded by MJFF and a consortium of companies, non-profit organizations and private individuals | Fox Insight, Sponsored by MJFF, Fox Insight is an online clinical study that collects genetic and self-reported data from a diverse group of people with and without Parkinson’s. Fox Insight aims to transform the search for Parkinson’s treatments by assembling a more complete understanding of the disease | Parkinson’s Disease Research Tools Consortium, The Foundation spearheads the Parkinson’s Disease Research Tools Consortium. This pre-competitive consortium helps MJFF and industry partners identify and develop new pre-clinical tools to address unmet research needs and accelerate experiments | Accelerating Medicines Partnership Parkinson’s Disease Program (AMP PD), This public-private partnership between MJFF, the National Institutes of Health (NIH) and five life sciences companies — and managed by the Foundation for the NIH — is advancing understanding, measurement and treatment of Parkinson’s disease. AMP PD supports cutting-edge work to tease apart microscopic differences in the cells of people with Parkinson’s disease from samples collected through MJFF- and NIH-supported studies | Parkinson’s Disease Education Consortium, Patient and caregiver education and engagement leads to better health outcomes for the individual and the collective through specialist care, use of new treatments and participation in clinical research. Our Parkinson’s Disease Education Consortium is an alliance of biotechnology and pharmaceutical firms that support our commitment to furnishing high-quality educational resources for the Parkinson’s community. Resources include annual education campaigns, webinars and podcasts, videos and website content, and in-person events | Parkinson’s Disease Therapeutics Conference, The only conference focused exclusively on Parkinson’s drug development, MJFF’s annual Parkinson’s Disease Therapeutics Conference attracts 300 research and business development professionals from academia and industry, and showcases the most promising, innovative research from the MJFF portfolio | MDS-PAS Movement Disorders School for Neurology Residents, In partnership with the International Parkinson and Movement Disorder Society (MDS), MJFF hosts the MDS-PAS Movement Disorders School for Neurology Residents. Through this program neurology residents learn about movement disorders and consider specializing in the field, growing the base of specialists caring for people with Parkinson’s disease | The Bachmann-Strauss Fellowship in Dystonia Research, In 2014, The Bachmann-Strauss Dystonia & Parkinson Foundation formed a collaborative research alliance with MJFF and established the Bachmann-Strauss Prize for Excellence in Dystonia Research to broaden public awareness and recognize key scientific discoveries in dystonia. In 2021, MJFF, with partners Bonnie and Tom Strauss, launchedthe Bachmann-Strauss Fellowship in Dystonia Researchto grow the base of scientists aiming to understand the causes of and contributors to dystonia | Shake It Up Foundation Australia, MJFF collaborates with the Shake It Up Foundation Australia to raise funds for PPMI and other Parkinson’s research being carried out in Australia. Together, the two groups capitalize on MJFF’s expertise in Parkinson’s drug development to ensure that funds are allocated to projects that will tangibly impact patients’ lives | The Michael Stern Parkinson’s Research Foundation, The Michael Stern Parkinson’s Research Foundation (MSPRF) was founded in 2001 by the late journalist, filmmaker and philanthropist Michael Stern. In the 15 years of its operation, MSPRF supported more than $46 million in Parkinson’s disease research. In 2015, the Stern Foundation named MJFF its successor organization and formed the Michael Stern Discovery Grants in Parkinson’s Science to advance research focused on the underlying cause, diagnosis and treatment of PD

Presupuesto: 111.187,07 €

Estudio multicéntrico de la eficacia del tratamiento único con BIC/FTC/TAF en pacientes penitenciarios institucionalizados que viven con VIH (Multicentre Study of The Efficacy of Single Treatment with BIC/FTC/TAF In Institutionalised Prison Patients Living with HIV)

Investigador principal: Alberto Romero (EM24)

Más información

Fechas: 05 de octubre de 2023 – x

Presupuesto: 42.895,00 €

Comorbidity of cHronic Pain and mood disorders: breaking the vicious cYcle (HaPpY)

Investigador principal: Esther Berrocoso (CO9)

Más información

Fechas: 01 de julio de 2021 – 30 de junio de 2025

Socios: Ipek Yalcin (Pharm.D., Ph.D). Research Director at CNRS (DR2). Co-head of “Neuroanatomy, Pain and Psychopathology”. Adjunct Professor at Psychiatry & Neuroscience at Laval University. Scientific Coordinator of HaPpY ITN project | Michel Barrot (Ph.D.). Research Director at CNRS. Director of the CNRS «Institut des Neurosciences Cellulaires & Intégratives» (UPR3212). Scientific Director of the EUR Euridol (Graduate School of Pain) at Strasbourg University. Neuroanatomy, Pain & Psychopathology» team co-leader | Pierre-Eric Lutz (M.D., Ph.D.). Associate Professor, CNRS. Researcher at Institut des Neurosciences Cellulaire et Intégratives | Professor Yves de Koninck (Ph.D). Professor of psychiatry & Neuroscience at Laval University. Adjunct Professor of Pharmacology & Therapeutics at McGill University. Scientific Director, Cervo Brain Research Center. Director of research, Quebec Integrated University Health and Social Services Center. Director, Neurophotonics Center. Scientific Director, Sentinel North Initiative. Fellow, Canadian Academy of Health Sciences. Fellow, Royal Society of Canada. Canada Research Chair in Chronic Pain and Related Brain Disorders – Tiers 1 | Tomi Rantamäki (Ph.D.). Associate Professor, University of Helsinki. Researcher at Laboratory of Neurotherapeutics, Regenerative Pharmacology Unit. Member of Council in the Brain Research Society Finland (BRSF). Member of Finnish Pharmaceutical Association and Finnish Pharmacological Society | Michelle Roche (Ph.D.). Senior Lecturer in Physiology at the National University of Ireland, Galway. Co-director for the Center for Pain Research. Deputy Director for the Galway Neuroscience Center | David Finn (Ph.D.). Professor at the National University of Ireland (NUI) Galway. Head of Pharmacology and Therapeutics Department. Research Officer, Galway Neuroscience Centre. Scientific Advisory Panel of the European College of Neuropsychopharmacology (ECNP) board member. Founding Co-Director of the Centre for Pain Research at the National University of Ireland (NUI) Galway. Member of the International Association for the Study of Pain (IASP) and European Pain Federation (EFIC) Presidential Task Forces for Cannabis, Cannabinoids and Chronic Pain | Esther Berrocoso (Ph.D.). University of Cadiz tenured Professor. Head of research group – Principal investigator at Instituto de Investigacion e Innovacion Biomédica de Cadiz | Frauke Nees (Ph.D.). Director of the Institute of Medical Psychology and Sociology. Professor at the Institute of Medical Psychology and Sociology, University Medical Center Schleswig-Holstein, Christian-Albrechts University, Campus Kiel | Herta Flor (Ph.D.). Scientific Director, Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim. Full Professor, Heidelberg University, Germany. Member of the Research Advisory Board of the Cluster of Excellence „NeuroCure“ at the Charité – Universitätsmedizin, Berlin, Germany. Spokesperson of the interdisciplinary graduate program “Translational Neurosciences” of the Collaborative Research Center 636, funded by the Deutsche Forschungsgemeinschaft. Member of the German Academy of Sciences Leopoldina. Member of the Academia Europaea | Hugo Almeida (Ph.D.). Adjunct Professor, Life and Health Sciences Research Institute, Do Minho University. Junior Researcher | Benoit Labonté (Ph.D.). Assistant Professor, Psychiatry and Neuroscience department, Medicine University, Laval University. Research Chair – North Sentinelle in molecular biology and mood disorders | Rohini Kuner (Ph.D.). Professor, Department of Pharmacology, INF 366, Heidelberg University. Group leader in the Molecular Medicine Partnership Unit. | Eric Salvat (M.D. & Ph.D.). Coordinator of the Center for Pain Evaluation and Treatment (CETD), Strasbourg University Hospital. Associated Professor. Doctor specialized in Pain Treatment | Jack Foucher (M.D. & Ph.D.). Coordinator at the Center of Non-Invasive neuro-Modulation (CEMNIS), Strasbourg University Hospital. Lecturer, Strasbourg University. Neurologist, Psychiatrist & Physiologist | Didier Bouhassira (M.D. & Ph.D.). Professor and Research Director, INSERM. Head of the «Pathophysiology and clinical pharmacology of pain» laboratory, Paris Saclay University. Neurologist, Universitary Hospital Paris Ile-de-France Ouest | Nadine Attal (M.D. & Ph.D.). Professor and Research co-Director, INSERM. Neurologist, Universitary Hospital Paris Ile-de-France Ouest. Researcher in the «Pathophysiology and clinical pharmacology of pain» laboratory, Paris Saclay University | Jean-Luc Néron, Ph.D. Secondments for 4 ESRs. Development and optimization of optogenetic tolos | Domitille Boudard, Ph.D. Secondment for 1 ESR. Management, communication and dissemination | Stéphanie Wagner, Ph.D/ Emile Andriambeloson. Secondment for 2 ESRs. Behavioral testing and data comparison | Matthieu Charvériat Ph.D. Secondment for 3 ESRs. Development of strategies for «bed to bedside» | Ewa Sokolowska, Ph.D./Jack Prenderville, Ph.D. Secondments for 2 ESRs. Entrepreneurial skills | Sam Kynman. Secondment for 1 ESR. Management, communication and dissemination | Augusto Eugénio Filipe Ph.D. Secondment for 2 ESRs. Product development and marketing | Frauke Nees Ph.D. Secondment for 1 ESR. Clinical coach / dissemination activites | European Network of Fibromyalgia Associations (Belgium) | Fybromyalgia France (France) | European Psychiatry Association (Belgium) | Société Française D’Etude et De Traitement De La Douleur (France) | Sociedad Espanola Del Dolor (Spain) | L’institut Français De Finlande (Finland) | Centro De Investigacion Biomedica En Red Salud Mental (Spain) | Alsace Biovalley (France) | Pain Alliance Europe (Belgium) | European Depression Association (Belgium) | European Brain Council (Belgium) | Association for the Improvement of Mental Health Programmes (Switzerland)

Presupuesto: 501.809,75 €

PremAtuRe nEwborn motor and cogNitive impairmenTs: Early diagnosis (PARENT)

Más información

Fechas: 01 de noviembre de 2020 – 30 de abril de 2025

Presupuesto: 501.809,76 €

A holistic approach to rocking your health (RYHEALTH)

Investigador principal: David Jiménez Pavon (CO8)

Más información

Fechas: 01 de noviembre de 2022 – 30 de abril de 2025

Socios: Universidad de Coimbra | Región de Västerbotten | Outdoor Against Cancer | Grupo de Escuelas de Anadia | Escuela International Montessori | Universidad de Cádiz

Presupuesto: 178.348,62 €

Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia (RECOGNISED)

Investigador principal: Mónica García Alloza (CO18)

Más información

Fechas: 01 de enero de 2020 – 31 de diciembre de 2024

Socios: FUNDACIO HOSPITAL UNIVERSITARI VALL D’HEBRON – INSTITUT DE RECERCA, SPAIN – Coordinator (Rafael Simo) | THE QUEEN’S UNIVERSITY OF BELFAST – THE QUEEN’S UNIVERSITY OF BELFAST, United Kingdom – Deputy Coordinator (Noemi Lois) | AIBILI – ASSOCIAÇÃO PARA INVESTIGAÇÃO BIOMÉDICA E INOVAÇÃO EM LUZ E IMAGEM, PORTUGAL (José Cunha-Vaz) | UNIVERSITAIR MEDISCH CENTRUM UTRECHT – UMC UTRECHT, THE NETHERLANDS (Geert J. Biessels) | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM – AMC, THE NETHERLANDS (Reinier Schlingemann) | UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA – UNITOV, ITALY (Simona Frontoni / Paolo Sbraccia) | OSPEDALE SAN RAFFAELE SRL – OSR, VIA OLGETTINA 60, MILANO 20132, ITALY (Gianpaolo Zerbini) | UNIVERSITA DEGLI STUDI DI MILANO – UMIL, Via Festa Del Perdono 7, MILANO 20122, ITALY (Tiziana Borsello) | SYDDANSK UNIVERSITET – SDU, DENMARK (Jakob Grauslund) | FUNDACIO ASSISTENCIAL DE MUTUA DE TERRASSA FUNDACIO PRIVADA CATALANA, SPAIN (Maria José Barahona) | INSTITUT CATALA DE LA SALUT – ICS, SPAIN (Xavier Valldeperas) | JAVNA USTANOVA UNIVERZITET CRNE GORE PODGORICA – UOM, MONTENEGRO (Nataša Popović) | KLINICKI CENTAR CRNE GORE PODGORICA – Clinical Centre of Montenegro, MONTENEGRO (Filip Vukmirović) | UNIVERSIDAD DE CADIZ – UCA, SPAIN (Mónica Garcia-Alloza) | EATRIS ERIC – EATRIS, THE NETHERLANDS (Anton Ussi) | ALZHEIMER EUROPE – AE, LUXEMBOURG (Jean Georges) | FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL – IDF EUROPE, BELGIUM (Sabine Dupont) | ANAXOMICS BIOTECH, S.L., SPAIN (Judith Farrés) | OXURION, BELGIUM (Tine Van Bergen) | GENESIS BIOMED, BALDIRI REIXAC 4, BARCELONA 08028, SPAIN (Josep Lluís Falcó) | MULTIMEDICA SPA, VIA GAUDENZIO FANTOLI 16/15 , MILANO 20138, ITALY (Stela Vujosevic)

Presupuesto: 229.672,50 €

Outdoor Against Cancer Connects Us (OACus)

Investigador principal: David Jiménez Pavon (CO8)

Más información

Fechas: 17 de junio de 2022 – 16 de diciembre de 2023

Socios: Universidad de Umeå | Región Västerbotten | Outdoor Against Cancer | ESV Múnich | Universidad de Patras | CreThiDev | Universidad de Palermo | CEIPES | LILT Palermo | Universidad de Cádiz | Universidad de Coimbra | CHUC | Liga Portuguesa Contra el Cáncer

Presupuesto: 156.220,00 €

PROGERIA

Investigador principal: Mario Cordero (EM4)

Más información

Fechas: 01 de septiembre de 2021 – 30 de agosto de 2023

Presupuesto: 126.478,73 €

REDES

nexMPI (COST)

Investigador principal: Daniel Ortega (CO24)

Fechas: 22 de octubre de 2024 – 21 de octubre de 2028

IMPROVE (COST)

Investigador principal: Raúl González Domínguez (CO28)

Fechas: 21 de octubre de 2022 – 20 de octubre de 2026

IMMUPARKNET (COST)

Investigador principal: Javier González Rosa (CO12)

Fechas: 20 de septiembre de 2022 – 19 de septiembre de 2026

Vermont Oxford Network (VON)

Investigador principal: Simón Lubián (CO20)

Fechas: 01 de enero de 2013 – x

Harvard Exchange Alumni Training Programm (HEAT-Network)

Investigador principal: Mónica García Alloza (CO18)

BBMRI-ERIC

EOSC Future

Investigador principal: Isabel Benavente (CO20)

Fechas: 2021 – 2025

FOSTREN (COST)

Investigador principal: José Mª Villagrán (EM10)

Fechas: 22 de octubre de 2020 – 21 de octubre de 2024

reSearch-EU (reSearch-EU)

Investigador principal: Carmen Castro González (CO5)

Fechas: 01 de enero de 2021 – 31 de diciembre de 2023

SEA-EU Alliance (SeaEU)

Investigador principal: Carmen Castro González (CO5)

Fechas: 2021 – 2023

BURDEN (COST)

Investigador principal: Mª José Santi Cano (EM16)

Fechas: 28 de octubre de 2019 – 27 de octubre de 2023

CA16102 (COST)

Investigador principal: José Miguel Mestre Navas (IN25)

Fechas: 2017 – 2021

CA16118 (COST)

Investigador principal: Luis Miguel Valor (CO16)

Fechas: 2017 – 2021

Resumen de privacidad

Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.